Cyrus Harmon
2023
In 2023, Cyrus Harmon earned a total compensation of $1.3M as Former Chief Research Officer and Former Chief Executive Officer at Olema Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $48,000 |
|---|---|
| Option Awards | $550,180 |
| Salary | $120,972 |
| Other | $615,678 |
| Total | $1,334,830 |
Harmon received $615.7K in other compensation, accounting for 46% of the total pay in 2023.
Harmon also received $48K in non-equity incentive plan, $550.2K in option awards and $121K in salary.
Rankings
In 2023, Cyrus Harmon's compensation ranked 866th out of 2,647 executives tracked by ExecPay. In other words, Harmon earned more than 67.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 866 out of 2,647 | 67th |
Division Manufacturing | 510 out of 1,447 | 65th |
Major group Chemicals And Allied Products | 346 out of 817 | 58th |
Industry group Drugs | 336 out of 783 | 57th |
Industry Pharmaceutical Preparations | 227 out of 555 | 59th |
Source: SEC filing on April 26, 2024.
Harmon's colleagues
We found three more compensation records of executives who worked with Cyrus Harmon at Olema Pharmaceuticals in 2023.